Predictive Oncology Inc (POAI) |
|
1.22 -0.03 (-2.4%)
|
03-07 04:40 |
|
Open: |
1.32 |
Pre. Close: |
1.25 |
|
High:
|
1.33 |
Low:
|
0.936 |
|
Volume:
|
8,340,082 |
Market Cap:
|
56M |
|
|
|
|
Predictive Oncology Inc. is focused on applying artificial intelligence (AI) to personalized medicine and drug discovery. It operates through its subsidiaries, Helomics Holding Corporation (Helomics), TumorGenesis Inc., Skyline Europe and Skyline Medical Inc. Helomics applies AI to its data gathered from patient tumors to both personalize cancer therapies for patients and focusses on the development of new-targeted therapies. Helomics’ clinical laboratory improvement amendments (CLIA)-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions. Its TumorGenesis Inc. is engaged in developing approach to tumors in the laboratory. Skyline Medical Inc. markets its STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.333 - 1.341 |
1.341 - 1.347 |
|
Low:
|
0.926 - 0.934 |
0.934 - 0.94 |
|
Close:
|
1.207 - 1.222 |
1.222 - 1.232 |
|
Technical analysis |
as of: 2021-03-05 5:12:06 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 2.08  One year: 2.69 |
| Support: |
Support1: 0.94 Support2: 0.78 |
| Resistance: |
Resistance1: 1.78 Resistance2: 2.30 |
| Pivot: |
1.63 |
| Moving Average: |
MA(5): 1.47 MA(20): 1.64
MA(100): 0.99  MA(250): 1.24 |
| MACD: |
MACD(12,26): 0.03 Signal(9): 0.11 |
| Stochastic oscillator: |
%K(14,3): 17.37 %D(3): 26.83 |
| RSI: |
RSI(14): 42.78 |
| 52-week: |
High: 4.42 Low: 0.63 Change(%): -44.5 |
| Average Vol(K): |
3-Month: 453771 10-Days: 453235 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.POAI has closed above bottom band by 8.3%. Bollinger Bands are 161.5% wider than normal. The large width of the bands suggest high volatility as compared to POAI's normal range. The bands have been in this wide range for 35 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Fri, 05 Mar 2021
Premarket Mover: Predictive Oncology Inc (POAI) Up 10.40% - InvestorsObserver
Thu, 04 Mar 2021
BioMedNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Leveraging AI, Proprietary Database to Improve Outcomes for Patients of Today and Tomorrow - StreetInsider.com
Tue, 02 Mar 2021
Predictive Oncology Inc (POAI) Stock Gains 15.44% This Week: Is It a Good Pick? - InvestorsObserver
Wed, 24 Feb 2021
Predictive Oncology: Potentially Undervalued Drug Discovery AI Company - Seeking Alpha
Tue, 23 Feb 2021
Predictive Oncology Announces Closing of $17.6 Million Private Placement Priced At-the-Market - GlobeNewswire
Thu, 18 Feb 2021
Predictive Oncology Announces $17.6 Million Private Placement Priced At-the-Market - GlobeNewswire
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Instruments & Supplies |
| Shares Out. (M) |
26 |
| Shares Float (M) |
17 |
|
% Held by Insiders
|
10.36 |
|
% Held by Institutions
|
2.17 |
|
Shares Short (K)
|
769 |
|
Shares Short P. Month (K)
|
270 |
Stock Financials |
|
EPS
|
-3.423 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
0.740 |
|
Profit Margin
|
|
|
Operating Margin
|
-843.72 |
|
Return on Assets (ttm)
|
-24.1 |
|
Return on Equity (ttm)
|
-169.8 |
|
Qtrly Rev. Growth
|
-8.0 |
|
Gross Profit (p.s.)
|
0.033 |
|
Sales Per Share
|
0.050 |
|
EBITDA (p.s.)
|
-0.387 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-13 |
|
Levered Free Cash Flow (M)
|
-4 |
Stock Valuations |
|
PE Ratio
|
-0.36 |
|
PEG Ratio
|
|
|
Price to Book value
|
1.65 |
|
Price to Sales
|
24.50 |
|
Price to Cash Flow
|
-2.52 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
